E-125 Beta

GPTKB entity

Statements (54)
Predicate Object
gptkbp:instance_of gptkb:chemical_compound
gptkbp:activities inhibits bacterial cell wall synthesis
gptkbp:application pharmaceutical research
gptkbp:class thiazole derivatives
gptkbp:clinical_trial ongoing
gptkbp:collaborations international pharmaceutical companies
gptkbp:composed_of amphiphilic nature
reaction of thiazole derivatives
gptkbp:dissolved soluble in DMSO
gptkbp:environmental_impact moderate toxicity
low environmental toxicity
gptkbp:financial_performance stable under normal conditions
gptkbp:future_plans combination therapies
exploring new formulations
https://www.w3.org/2000/01/rdf-schema#label E-125 Beta
gptkbp:ingredients C12 H15 N3 O3 S
gptkbp:invention gptkb:XYZ_Pharmaceuticals
patented
gptkbp:investment high potential in pharmaceuticals
gptkbp:is_analyzed_in NMR
HPLC
mass spectrometry
gptkbp:market not commercially available yet
gptkbp:melting_point 150 ° C
350 ° C
gptkbp:microtransactions active against Gram-positive bacteria
active against Gram-negative bacteria
gptkbp:pharmacokinetics inhibits bacterial growth
oral bioavailability under study
gptkbp:previous_name N-(4-(2-(4-(dimethylamino)phenyl)thiazol-4-yl)thiazol-2-yl)phenyl)acetamide
gptkbp:producer high yield
gptkbp:products E-124 Beta
gptkbp:receives_funding_from funded by government grants
funded by private investors
gptkbp:regulatory_compliance awaiting approval
gptkbp:research_areas gptkb:XYZ_University
ABC Research Lab
gptkbp:safety_features under evaluation
available in safety sheets
gptkbp:side_effect dizziness
headache
nausea
allergic reactions
gptkbp:social_structure contains thiazole rings
gptkbp:status under investigation
gptkbp:storage store in a cool, dry place
gptkbp:targets bacterial infections
gptkbp:type_of 123456-78-9
gptkbp:uses antimicrobial agent
gptkbp:was_a_response_to reacts with nucleophiles
gptkbp:weight 281.33 g/mol
gptkbp:year_created gptkb:2010
gptkbp:bfsParent gptkb:Sonic_the_Hedgehog_#291
gptkbp:bfsLayer 6